TELMISARTAN
Generic: TELMISARTAN
Solco Healthcare USManufacturer
ORALRoute
TELMISARTANActive Substance
2017-05-03Original Approval
TELMISARTAN is FDA application ANDA207882, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2019-04-01
Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.,Failed Impurities/Degradation Specifications; 18 month long term stability study.
Class I2021-03-17
Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (FormulationLabeling: Label-mixup
Class III2026-10-01
Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals ISuperpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
Class II2022-06-29
Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark PharmaceutiDefective Container: Recall of these batches has been initiated due to complaints of difficult to o
Class II2022-06-29
Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark PharmaceuDefective Container: Recall of these batches has been initiated due to complaints of difficult to o
Top Reported Reactions
1
FATIGUE
1,516 reports
2
NAUSEA
1,409 reports
3
DRUG INEFFECTIVE
1,287 reports
4
DIARRHOEA
1,267 reports
5
HEADACHE
1,250 reports
6
DYSPNOEA
1,206 reports
7
OFF LABEL USE
1,193 reports
8
FALL
1,166 reports
9
ARTHRALGIA
1,072 reports
10
BLOOD PRESSURE INCREASED
1,042 reports